Moderna announces plan to expand footprint in asia with four additional subsidiaries

Announcement reinforces moderna's commitment to asia and vision as a global commercial enterprise new subsidiaries to be established in malaysia, taiwan, singapore, and hong kong; providing local presence to support the delivery of mrna vaccines and therapeutics cambridge, ma / accesswire / february 15, 2022 / moderna, inc., (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced plans to expand its commercial network across asia with the addition of four new subsidiaries in malaysia, taiwan, singapore, and hong kong. this expansion comes as the company continues to scale up the manufacturing and distribution of its covid-19 vaccine and future mrna vaccines and therapeutics.
MRNA Ratings Summary
MRNA Quant Ranking